DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Nissen SE, Wolski K, Topol EJ.
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.
JAMA 2005;
294: 2581-2586
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.